Analysed SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) News Sources
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
19-05-2026
yahoo.com
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
01-06-2026
yahoo.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
25-06-2026
yahoo.com
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
28-07-2026
yahoo.com
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
07-08-2026
yahoo.com
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
19-08-2026
yahoo.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
19-08-2026
yahoo.com
What is the current price of SUNSHINE BIOPHARMA INC (SBFM:NASDAQ)?
The current price of SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) is $1.06.
SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) since the previous trading day is $-0.02.
SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) since the previous trading day is -1.8519%.
What is the most recent average sentiment score for SUNSHINE BIOPHARMA INC (SBFM:NASDAQ)?
The most recent average sentiment score for SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for SUNSHINE BIOPHARMA INC (SBFM:NASDAQ)?
The most recent sentiment for SUNSHINE BIOPHARMA INC (SBFM:NASDAQ) is .
SEC-8K** Filing Available For SUNSHINE BIOPHARMA INC (SBFM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.